GABAA Rε Activators

GABAA Rε Activators are a diverse class of chemical compounds that enhance the activity of GABAA Rε, a subunit of the GABA type A receptor, which is a key mediator of inhibitory neurotransmission in the central nervous system. Neurosteroids like Allopregnanolone and Tetrahydrodeoxycorticosterone act as positive allosteric modulators, binding to specific sites on the receptor complex and increasing the duration or frequency of channel opening events in response to GABA, thereby enhancing GABAergic inhibition. Similarly, Pregnenolone sulfate serves as a modulator that augments receptor activation when GABA is present. Anesthetic agents such as Etomidate and Propofol, and the volatile anesthetic Isoflurane, heighten GABAA Rε function by modulating the receptor's response to GABA, leading to an increase in the frequency or sensitivity of channel opening events.

Furthermore, benzodiazepines like Diazepam and hypnotic drugs such as Zolpidem selectively interact with GABAA Rε, facilitating the receptor's activity by increasing GABA-induced chloride channel opening frequency, which translates to enhanced neuronal inhibition. Flumazenil, although a benzodiazepine antagonist, can modulate GABAA Rε activity under specific conditions. Muscimol directly stimulates GABAA receptors, including GABAA Rε, by mimicking GABA's effect, thus directly opening the chloride channels. Gaboxadol offers selective activation of extrasynaptic GABAA Rε-containing receptors, highlighting a unique pathway of receptor modulation. Barbiturates like Phenobarbital extend the action of GABAA Rε through increased chloride channel opening duration, solidifying their role in enhancing inhibitory neurotransmission. Collectively, these activators operate through various mechanisms, all converging on the potentiation of GABAA Rε function without directly affecting the gene expression or synthesis of the receptor subunit.